ReviewNanoscale advances2026
MXene-integrated quantum dots: an innovative tool for next-generation healthcare applications.
Review in Nanoscale advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to their superior physical and chemical characteristics, MXene quantum dots (MXQDs) are regarded as outstanding zero-dimensional nanomaterials. The excitation-dependent emission properties, photostability, biocompatibility and dispersion stability of these QDs make them potential candidates for solving biomedical and environmental problems. Owing to their remarkable properties and biocompatibility, MXQDs represent a new generation of smart nanosystems used for cancer diagnostics and treatment, imaging, sensing, tissue engineering, and drug delivery. However, there are many problems related to their biodegradability, photoluminescence, long-term toxicity, and biodistribution properties, which need to be carefully considered. This review focuses on the current developments of MXQDs in healthcare applications and also on the current trends and future perspectives.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.